SG Americas Securities’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,557
| Closed | -$193K | – | 3092 |
|
|
2025
Q1 | $193K | Buy |
21,557
+2,355
| +12% | +$21.1K | ﹤0.01% | 2282 |
|
|
2024
Q4 | $181K | Buy |
19,202
+3,349
| +21% | +$31.6K | ﹤0.01% | 1990 |
|
|
2024
Q3 | $128K | Sell |
15,853
-146,535
| -90% | -$1.18M | ﹤0.01% | 2540 |
|
|
2024
Q2 | $1.38M | Sell |
162,388
-47,178
| -23% | -$400K | 0.01% | 1052 |
|
|
2024
Q1 | $1.88M | Buy |
209,566
+12,460
| +6% | +$112K | 0.01% | 829 |
|
|
2023
Q4 | $2.22M | Sell |
197,106
-55,503
| -22% | -$624K | 0.02% | 564 |
|
|
2023
Q3 | $2.18M | Buy |
252,609
+101,475
| +67% | +$876K | 0.02% | 612 |
|
|
2023
Q2 | $1.56M | Buy |
151,134
+121,126
| +404% | +$1.25M | 0.01% | 778 |
|
|
2023
Q1 | $326K | Buy |
30,008
+14,601
| +95% | +$159K | ﹤0.01% | 1883 |
|
|
2022
Q4 | $173K | Sell |
15,407
-11,858
| -43% | -$133K | ﹤0.01% | 2089 |
|
|
2022
Q3 | $276K | Buy |
27,265
+9,567
| +54% | +$96.8K | ﹤0.01% | 1829 |
|
|
2022
Q2 | $160K | Buy |
+17,698
| New | +$160K | ﹤0.01% | 2569 |
|
|
2022
Q1 | – | Sell |
-21,711
| Closed | -$240K | – | 2956 |
|
|
2021
Q4 | $240K | Sell |
21,711
-17,257
| -44% | -$191K | ﹤0.01% | 2324 |
|
|
2021
Q3 | $288K | Buy |
38,968
+30,926
| +385% | +$229K | ﹤0.01% | 2739 |
|
|
2021
Q2 | $117K | Buy |
+8,042
| New | +$117K | ﹤0.01% | 2333 |
|
|
2021
Q1 | – | Sell |
-42,230
| Closed | -$750K | – | 3018 |
|
|
2020
Q4 | $750K | Buy |
+42,230
| New | +$750K | ﹤0.01% | 1498 |
|
|
2020
Q3 | – | Sell |
-16,643
| Closed | -$349K | – | 2860 |
|
|
2020
Q2 | $349K | Sell |
16,643
-11,535
| -41% | -$242K | ﹤0.01% | 2065 |
|
|
2020
Q1 | $651K | Buy |
28,178
+22,143
| +367% | +$512K | 0.01% | 1301 |
|
|
2019
Q4 | $156K | Buy |
+6,035
| New | +$156K | ﹤0.01% | 2295 |
|
|
2019
Q2 | – | Sell |
-6,890
| Closed | -$156K | – | 2841 |
|
|
2019
Q1 | $156K | Buy |
+6,890
| New | +$156K | ﹤0.01% | 2395 |
|
|
2018
Q2 | – | Sell |
-5,347
| Closed | -$130K | – | 2970 |
|
|
2018
Q1 | $130K | Buy |
+5,347
| New | +$130K | ﹤0.01% | 2329 |
|
|
2017
Q4 | – | Sell |
-9,061
| Closed | -$310K | – | 2951 |
|
|
2017
Q3 | $310K | Buy |
9,061
+3,130
| +53% | +$107K | ﹤0.01% | 1912 |
|
|
2017
Q2 | $236K | Buy |
5,931
+443
| +8% | +$17.6K | ﹤0.01% | 2039 |
|
|
2017
Q1 | $202K | Sell |
5,488
-16,022
| -74% | -$590K | ﹤0.01% | 2160 |
|
|
2016
Q4 | $686K | Buy |
+21,510
| New | +$686K | 0.01% | 1374 |
|